AbbVie currently has more than 100 active partnerships with other
companies who share our commitment to oncology to strengthen our
pipeline, and with research and academic institutions, to deepen our
knowledge of core areas of biology.
In the UK we engage in innovative partnering and collaboration
opportunities that allow us to share novel science and technology and
enhance our ability to innovate for patients.
Abbvie was a founding partner in Genomics England’s Discovery Forum
which brought together academia, Government, the NHS and industry, to
increase collective understanding of the genetic basis of cancer.
And with the demands cancer places on the NHS, our expanding AbbVie
UK expert oncology team is working with regulatory and NHS bodies to
ensure as rapid access as possible to our treatments. At the same
time, generating evidence of the value these advancements bring to the
UK healthcare system.